Results 221 to 230 of about 35,808 (310)

Navigating the Complexities of Pemphigus Vulgaris: A Comprehensive Iranian Study

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.
We conducted a cross‐sectional analysis of 63 patients diagnosed with pemphigus vulgaris, confirmed by biopsy. Information was collected via telephone interviews. The research aimed to assess the demographic characteristics, initial symptoms, diagnosis delays, and treatment outcomes of the participants.
Delaram Moosavi   +7 more
wiley   +1 more source

The Role of Prophylaxis and Dietotherapy in Gynecology in the Context of the Interdisciplinary Nature of Genital Discomfort-A Pilot Report. [PDF]

open access: yesJ Clin Med
Jarząbek-Bielecka G   +7 more
europepmc   +1 more source

Role of LIGHT in the Inflammatory Mechanisms of Psoriasis via Upregulation of Proliferation and Cytokine Production of Keratinocytes

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.
ABSTRACT Background The pathogenesis of psoriasis is associated with abnormalities in immune pathways. HVEM is known as a receptor of LIGHT (homologous to lymphotoxins, inducible, and competes with HSV glycoprotein D), which is a newly identified member of the TNF superfamily.
Cheng‐bin Ye   +4 more
wiley   +1 more source

Predicting Role of Interleukin‐33 in Determining the Development and Severity of Atopic Dermatitis

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 2, February 2026.
ABSTRACT Introduction Atopic dermatitis (AD), also referred to as atopic eczema, is one of the most common immunological disorders in children. Previous studies have suggested potential roles of interleukin‐33 (IL‐33) in the onset and progression of AD.
Ali‐reza Ghasemiyeh   +5 more
wiley   +1 more source

Chronic Granulomatous Disease: Clinical and Molecular Characterization of Brazilian Patients

open access: yesThe Journal of Gene Medicine, Volume 28, Issue 2, February 2026.
Chronic granulomatous disease is a rare inborn error of immunity characterized by the deficient production of reactive oxygen species in phagocytes, which are used in pathogen elimination. Affected individuals become susceptible to severe infections.
Leonardo Martinello da Rosa   +4 more
wiley   +1 more source

Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome Patient

open access: yeseJHaem, Volume 7, Issue 1, February 2026.
ABSTRACT We report a 69‐year‐old man diagnosed as myelodysplastic syndrome and administrated with azacitidine and selinexor treatment. Then he was revealed high fever and multiple tender erythematous papules involving his mouth, back, upper and lower extremities, which were diagnosed as Sweet's syndrome by skin biopsy.
Liya Ma   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy